Skip to content
Evigrade
CriticalAntifungal, triazole×Highly selective α1A-adrenergic blocker

Updated · Methodology

Mechanism

The liver clears silodosin mainly through CYP3A4, alcohol dehydrogenase and UGT2B7, and P-glycoprotein (P-gp) transports it. Inhibitors of these enzymes and transporters, such as itraconazole, can change the levels of silodosin and its active metabolite (silodosin summary of product characteristics, SmPC, European Medicines Agency, EMA). Itraconazole strongly inhibits CYP3A4 and also inhibits P-gp (itraconazole SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Another strong CYP3A4 inhibitor, ketoconazole 400 mg, raised peak silodosin concentration 3.7-fold and the area under the curve (AUC) 3.1-fold (silodosin SmPC, EMA). A QT study used a 24 mg dose to model worst-case exposure, such as with strong CYP3A4 inhibitors, and this dose did not prolong the corrected QT interval (silodosin label, US Food and Drug Administration, FDA).

Symptoms

Higher silodosin levels strengthen its effect: blood pressure falls on standing up, with dizziness and, rarely, fainting (silodosin summary of product characteristics, SmPC, European Medicines Agency, EMA). Postural hypotension was the dose-limiting reaction in healthy men who took up to 48 mg a day (silodosin SmPC, EMA). The most common adverse effects of silodosin are ejaculation disorders (retrograde ejaculation, reduced or absent ejaculate), nasal congestion and diarrhoea (silodosin SmPC, EMA).

Management

The combination is contraindicated in the US silodosin label: silodosin must not be taken with strong CYP3A4 inhibitors, and the label names itraconazole among them (silodosin label, US Food and Drug Administration, FDA). European summaries of product characteristics (SmPC) are softer but also advise against the pair. The silodosin SmPC does not recommend silodosin with strong CYP3A4 inhibitors, including itraconazole (silodosin SmPC, European Medicines Agency, EMA). The itraconazole SmPC says to avoid silodosin during itraconazole treatment and for 2 weeks after it ends, unless the benefit outweighs the risk (itraconazole SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). If the combination cannot be avoided, watch for signs of a stronger silodosin effect and lower its dose or stop it if needed (itraconazole SmPC, AEMPS). At the first signs of orthostatic hypotension, such as postural dizziness, have the patient sit or lie down until the symptoms pass (silodosin SmPC, EMA). When starting silodosin, warn the patient about driving, operating machinery or other hazardous tasks (silodosin FDA label).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Itraconazole

Other interactions with Silodosin